ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE): $264M Department of Health and Human Services Contract
Summary
The Department of Health and Human Services awarded a $264M definitive contract to the private Albert B. Sabin Vaccine Institute for Marburg virus vaccine R&D and procurement over a 10-year period. This award reinforces federal commitment to biodefense but has no direct public company exposure.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The $264M Marburg vaccine contract is a significant biodefense award but goes to a private entity, limiting direct stock market implications.
- 2.The 10-year duration underscores long-term government commitment to medical countermeasure preparedness.
- 3.Investors should monitor broader biodefense spending trends rather than specific tickers from this award.
Market Implications
This contract does not directly move any public company's stock because the recipient is private. However, it adds to the narrative of increased government spending on pandemic preparedness, which may support valuations of publicly traded vaccine developers like Moderna ($MRNA) or Pfizer ($PFE) over the long term, though no immediate revenue impact is attributable. The contract's size ($264M over 10 years) is modest relative to the overall biopharma market, so sector-level effects are muted.
⚡ Government Convergence
This signal is one of the converging government actions below.
Over the last 90 days, 74 separate government actions have converged on Biodefense / Pandemic Preparedness. What that means: federal dollars are already moving — agencies are soliciting bids and awarding contracts, not just talking, and legislation and executive action are building the policy and funding tailwind behind it. When independent channels move together like this — 41 federal contracts, 29 procurement notices, 3 bills and 1 news — it's the clearest early tell that Washington is committing to biodefense / pandemic preparedness, the kind of build-up that reshapes the sector well before it's obvious in the headlines.
Converging government actions
- BillBeagle Brigade Act of 2023 · 2024-12-23
- BillNo Flight, No Fight Act of 2026 · 2026-02-05
- Procurement noticeSources Sought Notice - Pandemic Preparedness Plan Evaluation · 2026-05-13
- Procurement noticeRFI - Medical Countermeasures for the Treatment of Drug-Resistant Fungal Infections · 2026-05-21
- Procurement noticeRPP: BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-02
- Procurement noticeRequest for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-03
- Procurement noticeMedical Waste Incineration Services � Fort Detrick, MD · 2026-06-03
- Procurement noticeRequest for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-11
- ContractEMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.: ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) · 2026-06-26
- Procurement noticePresolicitation Notice - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response · 2026-07-30
- ContractSIGA TECHNOLOGIES, INC.: PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF · 2026-08-24
- Procurement noticeBARDA Device Development for Scientists Training · 2026-10-02
- Procurement noticeMARINE RESOURCE TECHNICAL SERVICES THROUGHOUT THE NAVAL FACILITIES ENGINEERING SYSTEMS COMMAND (NAVFAC) PACIFIC AREA OF RESPONSIBILITY · 2026-10-05
- Procurement noticeBARDA Device Development for Scientists Training · 2026-10-05
Full Analysis
The contract, titled 'Strategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (SMART-PREP),' was awarded by the Office of Assistant Secretary for Preparedness and Response (ASPR) to the Albert B. Sabin Vaccine Institute, a private nonprofit focused on vaccine development. The $264M award spans from May 2026 to April 2036, indicating a long-term government investment in Marburg virus countermeasures. As the recipient is not publicly traded, there is no direct equity impact on listed companies. However, this contract signals sustained federal prioritization of biodefense and pandemic preparedness, which benefits the broader healthcare sector involved in vaccine and therapeutic development. While no specific public companies are named, the contract may indirectly support demand for contract research organizations, raw material suppliers, and manufacturing partners, though these are not explicitly identified in the award. The absence of directly related legislation among the provided bill signals suggests this funding stems from existing appropriations rather than new authorization. Historically, large biodefense contracts like this one reinforce the government's role as a stable, multi-year customer for vaccine developers, but without a public company recipient, the market impact is diffuse.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE): $224M Department of Health and Human Services Contract
SEQIRUS INC: $42.8M Department of Health and Human Services Contract
MERCK SHARP & DOHME LLC: $156M Department of Health and Human Services Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Contract Details
Recipient
ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE)
Award Amount
$263,613,186
Awarding Agency
Department of Health and Human Services
Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Contract Type
DEFINITIVE CONTRACT
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →